Product Information
MINOCYCLINE 75 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4185 per EA under NDC 57664085288. Its NADAC has been published 635 times since Dec 25, 2013.
FDA first approved this application on May 13, 2013.
Strength
75 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
57664085288
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090867FDA Approved
5/13/2013
On Market Since
5/13/2013
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 75 MG CAPSULE has been published 635 times since Dec 25, 2013, and over the history we have for it it has risen 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4185 per EA |
|---|---|
| All-time high | $0.5390 (May 16, 2018) |
| All-time low | $0.2623 (Aug 20, 2014) |
| 52-week high | $0.4410 |
| 52-week low | $0.4004 |
| Median price | $0.4066 |
| Average price | $0.3995 |
| Largest weekly change | +42.7% (Jan 21, 2015) |
| Weeks tracked | 635 |
| Tracking since | Dec 25, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-5.1%
3Y
-2.6%
5Y
-5.6%
All
+32.3%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Minocycline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINOCYCLINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 75 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.4185 per EA (NDC 57664085288), effective Feb 18, 2026.
How has the price of MINOCYCLINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 75 MG CAPSULE has risen 32.3%. It has been tracked across 635 weekly CMS publications since Dec 25, 2013.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 75 MG CAPSULE?
Since Dec 25, 2013, the NADAC for MINOCYCLINE 75 MG CAPSULE has ranged from a low of $0.2623 (Aug 20, 2014) to a high of $0.5390 (May 16, 2018), with a median of $0.4066 per EA.
Are there cheaper alternatives to MINOCYCLINE 75 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MINOCYCLINE 75 MG CAPSULE, is $0.3968 per EA — about 5% below MINOCYCLINE 75 MG CAPSULE.
Who manufactures MINOCYCLINE 75 MG CAPSULE?
MINOCYCLINE 75 MG CAPSULE (NDC 57664085288) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.